Question follow-through · 2751
Obesity: Health Services
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NICE guidance on GLP-1 medications for obesity is implemented consistently across Integrated Care Boards; and if he will review the methodology us
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 19 May 2026
- Target answer date
- 21 May 2026
- Answer
- 2 Jun 2026 · 14 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Hormone Replacement Therapy · 14 Sept 2026
- Health Services: Women · 14 Sept 2026
- Health Services: Women · 14 Sept 2026
- Health Services: Women · 14 Sept 2026
- Health Services: Women · 14 Sept 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
19 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NICE guidance on GLP-1 medications for obesity is implemented consistently across Integrated Care Boards; and if he will review the methodology us
21 May 2026
Target answer date
Date supplied by the official written-questions record.
2 Jun 2026
Answer published
Integrated care boards (ICBs) are legally required to make funding available for medicines recommended by the National Institute for Health and Care Excellence (NICE) in line with NICE guidance and the NICE Funding Variation for tirzepatide. NHS England i...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Hormone Replacement Therapy
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what discussions she has had with the National Institute for Health and Care Excellence on its Topic Selection processes for hormone-based therapies used in the treatment of menopause and female se
Health Services: Women
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of NICE's topic selection and health technology assessment processes in prioritising conditions that predominantly affect women, including menopause-rel
Health Services: Women
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what assessment she has made of the effectiveness of NICE in addressing medical and clinical misogyny within health technology assessment and clinical guideline development; and what steps she is t
Health Services: Women
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what discussions she has had with NICE on its appraisal and topic selection processes to ensure they comply with the Public Sector Equality Duty in relation to women's health.
Health Services: Women
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what discussions she has had with NICE on its work programme and the objectives of the Women's Health Strategy to ensure that women's health technologies and treatments are prioritised within futur